Other Intangible Assets (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended	6 Months Ended
	Jun. 30, 2011	Jun. 30, 2011 year day	Jun. 30, 2010	Dec. 31, 2010	Dec. 31, 2009
Other Intangible Assets, Net
Other Intangible Assets, Gross	$ 3,447.0	$ 3,447.0		$ 2,678.1
Finite Lived Intangible Assets Gross	3,296.4	3,296.4		2,538.4
Other Intangible Assets, Accumulated Amortization	(767.6)	(767.6)		(699.2)
Other Intangible Assets, Net, Total	2,679.4	2,679.4	1,653.1	1,978.9	1,790.7
Other Intangible Assets, Acquired During Period		711.5	2.7
Other Intangible Assets, Future Amortization Expense	183.0
Acquired Finite-lived Intangible Asset, Weighted Average Useful Life (in Years)		18
Specialty Pharmaceuticals
Other Intangible Assets, Net
Other Intangible Assets, Net, Total	2,184.5	2,184.5		1,482.9
Human Genetic Therapies
Other Intangible Assets, Net
Other Intangible Assets, Net, Total	494.9	494.9		496.0
Acquired Currently Marketed Products
Other Intangible Assets, Net
Other Intangible Assets, Gross	2,562.2	2,562.2		2,516.4
Acquired In Process Research and Development
Other Intangible Assets, Net
Other Intangible Assets, Gross	150.6	150.6		139.7
Other Intangible Assets
Other Intangible Assets, Net
Other Intangible Assets, Gross	24.2	24.2		22.0
DERMAGRAFTCurrentlyMarketedProductsMember Member
Other Intangible Assets, Net
Finite Lived Intangible Assets Gross	$ 710.0	$ 710.0		$ 0